vs
Doximity, Inc.（DOCS）与和黄医药（HCM）财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是Doximity, Inc.的1.5倍（$270.8M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs 0.7%，领先32.5%），Doximity, Inc.同比增速更快（9.8% vs -16.5%）
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
DOCS vs HCM — 直观对比
营收规模更大
HCM
是对方的1.5倍
$185.1M
营收增速更快
DOCS
高出26.3%
-16.5%
净利率更高
DOCS
高出32.5%
0.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $270.8M |
| 净利润 | $61.6M | $2.0M |
| 毛利率 | 89.9% | 37.7% |
| 营业利润率 | 38.9% | -13.2% |
| 净利率 | 33.3% | 0.7% |
| 营收同比 | 9.8% | -16.5% |
| 净利润同比 | -18.1% | -83.6% |
| 每股收益（稀释后） | $0.31 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCSHCM
| Q4 25 | $185.1M | $270.8M | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $145.9M | $277.7M | ||
| Q1 25 | $138.3M | $324.5M | ||
| Q4 24 | $168.6M | — | ||
| Q3 24 | $136.8M | — | ||
| Q2 24 | $126.7M | $305.7M | ||
| Q1 24 | $118.1M | — |
净利润DOCSHCM
| Q4 25 | $61.6M | $2.0M | ||
| Q3 25 | $62.1M | — | ||
| Q2 25 | $53.3M | $455.0M | ||
| Q1 25 | $62.5M | $11.9M | ||
| Q4 24 | $75.2M | — | ||
| Q3 24 | $44.2M | — | ||
| Q2 24 | $41.4M | $25.8M | ||
| Q1 24 | $40.6M | — |
毛利率DOCSHCM
| Q4 25 | 89.9% | 37.7% | ||
| Q3 25 | 90.3% | — | ||
| Q2 25 | 89.2% | 0.1% | ||
| Q1 25 | 89.5% | 48.0% | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 90.0% | — | ||
| Q2 24 | 89.3% | 41.1% | ||
| Q1 24 | 89.4% | — |
营业利润率DOCSHCM
| Q4 25 | 38.9% | -13.2% | ||
| Q3 25 | 37.8% | — | ||
| Q2 25 | 37.4% | -1.3% | ||
| Q1 25 | 35.2% | -5.0% | ||
| Q4 24 | 47.4% | — | ||
| Q3 24 | 38.8% | — | ||
| Q2 24 | 36.4% | -9.0% | ||
| Q1 24 | 35.5% | — |
净利率DOCSHCM
| Q4 25 | 33.3% | 0.7% | ||
| Q3 25 | 36.8% | — | ||
| Q2 25 | 36.5% | 163.8% | ||
| Q1 25 | 45.2% | 3.7% | ||
| Q4 24 | 44.6% | — | ||
| Q3 24 | 32.3% | — | ||
| Q2 24 | 32.7% | 8.4% | ||
| Q1 24 | 34.4% | — |
每股收益（稀释后）DOCSHCM
| Q4 25 | $0.31 | $0.00 | ||
| Q3 25 | $0.31 | — | ||
| Q2 25 | $0.27 | $0.52 | ||
| Q1 25 | $0.31 | $0.01 | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.22 | — | ||
| Q2 24 | $0.21 | $0.03 | ||
| Q1 24 | $0.20 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $1.4B |
| 总债务越低越好 | — | $93.2M |
| 股东权益账面价值 | $979.3M | $1.2B |
| 总资产 | $1.2B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资DOCSHCM
| Q4 25 | $64.8M | $1.4B | ||
| Q3 25 | $169.2M | — | ||
| Q2 25 | $137.3M | $1.4B | ||
| Q1 25 | $209.6M | $836.1M | ||
| Q4 24 | $165.3M | — | ||
| Q3 24 | $184.2M | — | ||
| Q2 24 | $111.4M | $802.5M | ||
| Q1 24 | $96.8M | — |
总债务DOCSHCM
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M | ||
| Q1 24 | — | — |
股东权益DOCSHCM
| Q4 25 | $979.3M | $1.2B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $1.1B | $759.9M | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $961.2M | — | ||
| Q2 24 | $913.6M | $740.1M | ||
| Q1 24 | $901.4M | — |
总资产DOCSHCM
| Q4 25 | $1.2B | $1.8B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | $1.3B | ||
| Q1 24 | $1.1B | — |
负债/权益比DOCSHCM
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.9M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | — | $3.4M |
| 自由现金流率自由现金流/营收 | — | 1.2% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | 0.99× | 4.21× |
| 过去12个月自由现金流最近4个季度 | — | $-96.2M |
8季度趋势，按日历期对齐
经营现金流DOCSHCM
| Q4 25 | $60.9M | $8.2M | ||
| Q3 25 | $93.9M | — | ||
| Q2 25 | $62.1M | $-72.9M | ||
| Q1 25 | $98.5M | $40.3M | ||
| Q4 24 | $65.2M | — | ||
| Q3 24 | $68.3M | — | ||
| Q2 24 | $41.2M | $-39.8M | ||
| Q1 24 | $63.9M | — |
自由现金流DOCSHCM
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M | ||
| Q1 24 | — | — |
自由现金流率DOCSHCM
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% | ||
| Q1 24 | — | — |
资本支出强度DOCSHCM
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | 0.0% | 2.4% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | 3.3% | ||
| Q1 24 | 0.0% | — |
现金转化率DOCSHCM
| Q4 25 | 0.99× | 4.21× | ||
| Q3 25 | 1.51× | — | ||
| Q2 25 | 1.16× | -0.16× | ||
| Q1 25 | 1.58× | 3.38× | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 1.55× | — | ||
| Q2 24 | 1.00× | -1.54× | ||
| Q1 24 | 1.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
HCM
暂无分部数据
